The Ministry of Chemicals and Fertilizers has issued an important update through the National Pharmaceutical Pricing Authority (NPPA). The ministry has extended the existing ceiling prices for orthopaedic knee implants used in knee replacement procedures. These prices were originally fixed in August 2017 to avoid sudden spikes in treatment costs and have been renewed several times based on public interest.
The earlier extension was valid until 15 November 2025. With the latest order, the same ceiling prices will now continue until 15 November 2026, or until the government releases a new directive. This ensures consistent pricing for hospitals and manufacturers while providing financial safety to patients undergoing knee replacement surgery.
All notes and conditions included in the original 2017 notification will stay active during this extended period. The decision highlights the ministry’s ongoing focus on transparency, fair pricing, and accessible healthcare for those who depend on crucial orthopaedic implants.